UBS’s iPath Pure Beta Lead ETN LEDD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$59K Buy
1,631
+712
+77% +$27.7K ﹤0.01% 6644
2014
Q2
$35K Buy
919
+600
+188% +$22.6K ﹤0.01% 7373
2014
Q1
$12K Buy
+319
New +$12.1K ﹤0.01% 8730
2013
Q4
Sell
-61
Closed -$2K 11023
2013
Q3
$2K Sell
61
-100
-62% -$3.85K ﹤0.01% 10026
2013
Q2
$6K Buy
+161
New +$6.01K ﹤0.01% 9157

Other funds holding LEDD

UBS's LEDD Position: Q3 2014 in Review

UBS increased its iPath Pure Beta Lead ETN (LEDD) stake by 77% in Q3 2014, buying an estimated $27.7K and bringing the position to 1,631 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #6644.

UBS first reported a position in LEDD in Q2 2013 and has held it in 5 quarters since. 2 funds tracked by Wall St. Rank hold LEDD as of Q3 2014.

  • UBS held 1,631 shares of iPath Pure Beta Lead ETN worth $59K as of Q3 2014.
  • UBS bought 712 iPath Pure Beta Lead ETN shares in Q3 2014, an estimated $27.7K.
  • iPath Pure Beta Lead ETN made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6644 holding.
  • UBS first reported a position in iPath Pure Beta Lead ETN in Q2 2013 and has held it in 5 quarters since.
  • 2 funds tracked by Wall St. Rank held iPath Pure Beta Lead ETN as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.